Nitric oxide synthase inhibition during development: Effect on apoptotic death of dopamine neurons

Developmental Brain Research

Volumn 138, Issue 2, 2002, Pages 147-153

  Groc, Laurent ^a,b,c,e   Jackson Hunter, Tangella ^a,b   Jiang, Hao ^a,b   Bezin, Laurent ^d   Koubi, David ^a,b   Corcoran, George B ^c   Levine, Robert A ^a,b,c  

^a HENRY FORD HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cell death; Development; Dopamine; Nitric oxide synthase

Indexed keywords

7 NITROINDAZOLE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; STAINING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BODY WEIGHT; DOPAMINE; ENZYME INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDAZOLES; NADPH DEHYDROGENASE; NEURONS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0037145435     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(02)00464-9     Document Type: Article

References (29)

1. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32:1998;117-131.
2. Canals S., Casarejos M.J., Rodriguez-Martin E., de Bernardo S., Mena M.A. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures. J. Neurochem. 76:2001;56-68.
3. Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Brain Res. Rev. 32:2000;476-509.
4. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
5. Dehmer T., Lindenau J., Haid S., Dichgans J., Schulz J.B. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 74:2000;2213-2216.
6. El-Khodor B.F., Kholodilov N.G., Yarygina O., Burke R.E. The expression of mRNAs for the proteasome complex is developmentally regulated in the rat mesencephalon. Brain Res. Dev. Brain Res. 129:2001;47-56.
7. Finney E.M., Shatz C.J. Establishment of patterned thalamocortical connections does not require nitric oxide synthase. J. Neurosci. 18:1998;8826-8838.
8. Gally J.A., Montague P.R., Reeke G.N. Jr., Edelman G.M. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc. Natl. Acad. Sci. USA. 87:1990;3547-3551.
9. Groc L., Bezin L., Foster J.A., Jiang H., Jackson T.S., Weissmann D., Levine R.A. Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development. Neurochem. Int. 39:2001;127-133.
10. Groc L., Bezin L., Jiang H., Jackson T.S., Levine R.A. Bax, Bcl-2 and cyclin expression and apoptosis in rat substantia nigra during development. Neurosci. Lett. 306:2001;198-202.
11. Groc L., Levine R.A., Foster J.A., Normile H.J., Weissmann D., Bezin L. Evidence of deprenyl-insensitive apoptosis of nigral dopamine neurons during development. Brain Res. Dev. Brain Res. 120:2000;95-98.
12. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1273-1286.
13. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
14. Jackson-Lewis V., Vila M., Djaldetti R., Guegan C., Liberatore G., Liu J., O'Malley K.L., Burke R.E., Przedborski S. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J. Comp. Neurol. 424:2000;476-488.
15. Jeon B.S., Kholodilov N.G., Oo T.F., Kim S.Y., Tomaselli K.J., Srinivasan A., Stefanis L., Burke R.E. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J. Neurochem. 73:1999;322-333.
16. Kuhn D.M., Aretha C.W., Geddes T.J. Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration. J. Neurosci. 19:1999;10289-10294.
17. Lin J.Y., Lipski J. Dopaminergic substantia nigra neurons express functional nmda receptors in postnatal rats. J. Neurophysiol. 85:2001;1336-1339.
18. Marti M.J., James C.J., Oo T.F., Kelly W.J., Burke R.E. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 17:1997;2030-2039.
19. Matthews R.T., Beal M.F., Fallon J., Fedorchak K., Huang P.L., Fishman M.C., Hyman B.T. MPP+ induced substantia nigra degeneration is attenuated in nNOS knockout mice. Neurobiol. Dis. 4:1997;114-121.
20. Moore P.K., Handy R.L. Selective inhibitors of neuronal nitric oxide synthase - is no NOS really good NOS for the nervous system? Trends Pharmacol. Sci. 18:1997;204-211.
21. Noguchi S., Jianmongkol S., Bender A.T., Kamada Y., Demady D.R., Osawa Y. Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase. J. Biol. Chem. 275:2000;2376-2380.
22. Oo T.F., Burke R.E. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev. Brain Res. 98:1997;191-196.
23. Prickaerts J., De Vente J., Markerink-Van Ittersum M., Steinbusch H.W. Behavioural, neurochemical and neuroanatomical effects of chronic postnatal N-nitro-L-arginine methyl ester treatment in neonatal and adult rats. Neuroscience. 87:1998;181-195.
24. Son H., Hawkins R.D., Martin K., Kiebler M., Huang P.L., Fishman M.C., Kandel E.R. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell. 87:1996;1015-1023.
25. Strata F., Atzori M., Molnar M., Ugolini G., Berretta N., Cherubini E. Nitric oxide sensitive depolarization-induced hyperpolarization: a possible role for gap junctions during development. Eur. J. Neurosci. 10:1998;397-403.
26. Terada H., Nagai T., Okada S., Kimura H., Kitahama K. Ontogenesis of neurons immunoreactive for nitric oxide synthase in rat forebrain and midbrain. Brain Res. Dev. Brain Res. 128:2001;121-137.
27. Van Muiswinkel F.L., Drukarch B., Steinbusch H.W., De Vente J. Sustained pharmacological inhibition of nitric oxide synthase does not affect the survival of intrastriatal rat fetal mesencephalic transplants. Brain Res. 792:1998;48-58.
28. Virgili M., Monti B., LoRusso A., Bentivogli M., Contestabile A. Developmental effects of in vivo and in vitro inhibition of nitric oxide synthase in neurons. Brain Res. 839:1999;164-172.
29. Wu H.H., Selski D.J., El-Fakahany E.E., McLoon S.C. The role of nitric oxide in development of topographic precision in the retinotectal projection of chick. J. Neurosci. 21:2001;4318-4325.